Andres-Ejarque, R., Ale, H. B., Grys, K., Tosi, I., Solanky, S., Ainali, C., . . . Consortium, t. P. (2021). Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. Nature Portfolio.
Style de citation Chicago (17e éd.)Andres-Ejarque, Rosa, et al. Enhanced NF-κB Signaling in Type-2 Dendritic Cells at Baseline Predicts Non-response to Adalimumab in Psoriasis. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Andres-Ejarque, Rosa, et al. Enhanced NF-κB Signaling in Type-2 Dendritic Cells at Baseline Predicts Non-response to Adalimumab in Psoriasis. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.